These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31739194)

  • 1. Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.
    Espericueta V; Manughian-Peter AO; Bally I; Thielens NM; Fraser DA
    Mol Immunol; 2020 Jan; 117():65-72. PubMed ID: 31739194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.
    Fraser DA; Laust AK; Nelson EL; Tenner AJ
    J Immunol; 2009 Nov; 183(10):6175-85. PubMed ID: 19864605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
    Donat C; Thanei S; Trendelenburg M
    Front Immunol; 2019; 10():2712. PubMed ID: 31824501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.
    Gu C; Jenkins SA; Xue Q; Xu Y
    J Immunol; 2012 May; 188(9):4421-31. PubMed ID: 22442442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory roles of C1q.
    Lu J; Wu X; Teh BK
    Immunobiology; 2007; 212(4-5):245-52. PubMed ID: 17544810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.
    Bobak DA; Gaither TA; Frank MM; Tenner AJ
    J Immunol; 1987 Feb; 138(4):1150-6. PubMed ID: 3492544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
    Fraser DA; Tenner AJ
    J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
    Bobak DA; Frank MM; Tenner AJ
    Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.
    Tan LA; Yang AC; Kishore U; Sim RB
    Protein Cell; 2011 Apr; 2(4):320-32. PubMed ID: 21574022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.
    Pondman KM; Pednekar L; Paudyal B; Tsolaki AG; Kouser L; Khan HA; Shamji MH; Ten Haken B; Stenbeck G; Sim RB; Kishore U
    Nanomedicine; 2015 Nov; 11(8):2109-18. PubMed ID: 26169151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q.
    Ho MM; Manughian-Peter A; Spivia WR; Taylor A; Fraser DA
    Atherosclerosis; 2016 Oct; 253():38-46. PubMed ID: 27573737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.
    Clarke EV; Weist BM; Walsh CM; Tenner AJ
    J Leukoc Biol; 2015 Jan; 97(1):147-60. PubMed ID: 25381385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The classical and regulatory functions of C1q in immunity and autoimmunity.
    Lu JH; Teh BK; Wang Ld; Wang YN; Tan YS; Lai MC; Reid KB
    Cell Mol Immunol; 2008 Feb; 5(1):9-21. PubMed ID: 18318990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of C1q With Pentraxin 3 and IgM Revisited: Mutational Studies With Recombinant C1q Variants.
    Bally I; Inforzato A; Dalonneau F; Stravalaci M; Bottazzi B; Gaboriaud C; Thielens NM
    Front Immunol; 2019; 10():461. PubMed ID: 30923526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins.
    Spivia W; Magno PS; Le P; Fraser DA
    Inflamm Res; 2014 Oct; 63(10):885-93. PubMed ID: 25091012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q and phagocytosis: the perfect complement to a good meal.
    Galvan MD; Greenlee-Wacker MC; Bohlson SS
    J Leukoc Biol; 2012 Sep; 92(3):489-97. PubMed ID: 22715140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo.
    Ogden CA; Kowalewski R; Peng Y; Montenegro V; Elkon KB
    Autoimmunity; 2005 Jun; 38(4):259-64. PubMed ID: 16206508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.
    Tavano R; Gabrielli L; Lubian E; Fedeli C; Visentin S; Polverino De Laureto P; Arrigoni G; Geffner-Smith A; Chen F; Simberg D; Morgese G; Benetti EM; Wu L; Moghimi SM; Mancin F; Papini E
    ACS Nano; 2018 Jun; 12(6):5834-5847. PubMed ID: 29750504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages.
    Pondman KM; Sobik M; Nayak A; Tsolaki AG; Jäkel A; Flahaut E; Hampel S; Ten Haken B; Sim RB; Kishore U
    Nanomedicine; 2014 Aug; 10(6):1287-99. PubMed ID: 24607938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
    Gullstrand B; Mårtensson U; Sturfelt G; Bengtsson AA; Truedsson L
    Clin Exp Immunol; 2009 May; 156(2):303-11. PubMed ID: 19302245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.